Clinical Trial Update: Memantine as an Additive Therapy in Patients With Traumatic Brain Injury [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating memantine as an add-on therapy for mild and moderate traumatic brain injury; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Mansoura University | Conditions: Mild Traumatic Brain Injury, Moderate Traumatic Brain Injury (TBI) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING